홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.1
  1. 홈
  2. /반응

2(5H)-Furanone, 5-hydroxy-4-methyl- → ethyl [4-methyl-6-oxopyridazin-1(6H)-yl]acetate

HRID 1947709
인쇄

반응식

HRID 1947709 반응식
O[CH:2]1[O:6][C:5](=O)[CH:4]=[C:3]1[CH3:8].Cl.[NH:10]([CH2:12][C:13]([O:15][CH2:16][CH3:17])=[O:14])[NH2:11]>C(O)C>[CH3:2][C:3]1[CH:8]=[N:11][N:10]([CH2:12][C:13]([O:15][CH2:16][CH3:17])=[O:14])[C:5](=[O:6])[CH:4]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 1153012(5H)-Furanone, 5-hydroxy-4-methyl-HCID 11593468Acetic acid, 2-hydrazinyl-, ethyl ester, hydrochloride (1:1)

생성물 1

HCID 77231410ethyl [4-methyl-6-oxopyridazin-1(6H)-yl]acetate

시약·촉매·용매 1

HCID 702Ethanol용매

실험 절차

5-Hydroxy-4-methylfuran-2(5H)-one (1.19 g, 10.4 mmol) and ethyl hydrazinoacetate hydrochloride (1.61 g, 10.4 mmol) in 95% ethanol (20 mL) was refluxed for 2 h. Removal of the solvent in vacuo followed by purification using a Biotage Horizon® system (0-50% ethyl acetate/hexanes mixture) gave ethyl [4-methyl-6-oxopyridazin-1(6H)-yl]acetate as a yellow crystalline. LC/MS 219.2 (M+23).

후처리

  1. customRemoval of the solvent in vacuo
  2. customfollowed by purification

출처 및 근거

ORD 기록
ord-ce6909f73aff4620aa9cbd906c15e233
출처 데이터셋
uspto-grants-2013_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08399480B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트